New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug
... and increase healthcare costs
- Drug
interaction increases annual hospital costs by nearly 40 ... and further strengthens the observation that this
interaction exists between PPIs and clopidogrel and impairs ... the totality of the evidence generated on this
interaction and the known benefits of clopidogrel in reducing ...
BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
... on the projects, as well as
fostering broader
interaction between the two institutions. This
arrangement ... knowledge about the life of biofilms and
their
interaction with surfaces. George Whitesides, Woodford L. and ... the
symposium.
The study of biofilms and their
interaction with surfaces has gained
worldwide interest as ...
Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
... the duration of treatment.
-- The drug-drug
interaction potential of APTIVUS/r when co-administered ... hepatic impairment. -- The drug-drug
interaction potential of APTIVUS/r when co-administered ... events or loss of efficacy. -- A drug
interaction study in healthy subjects has shown that ...
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
... niacin in ACUROX(R) Tablets when taken at the recommended dose.
The
interaction Between Opioids and Alcohol: Results from a Global Literature Review
... examined the extent of the pharmacokinetic (PK) and pharmacodynamic (PD)
interaction between them, particularly when taken at therapeutic doses. A literature ...
D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients
... in January 2008. The
program included additional toxicity studies, a drug
interaction study with
rtPA, and an
interaction study with warfarin in healthy volunteers, as well
as scale-up and ...
Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
... New York University more than ten years ago regarding a direct physical
interaction between the beta amyloid protein and melatonin, a close structural homolog of OXIGON(TM). The
interaction was shown to involve four specific amino acids, which now are known to ...
Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
... (Chalfont St. Giles, UK), the
world leading provider of molecular
interaction analysis tools, and Uppsala
University (Sweden). The collaboration ... utilising its
proprietary methodologies to evaluate the biophysical
interaction of
molecules in order to generate novel therapeutics. The company was spun ...
New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis
... of RA, novel treatment pathways as well as
improved patient-provider
interaction and patient care. While research is
still underway, the REF is encouraged ... prevent early RA from amplifying.
Health Literacy and Patient-Physician
interaction Dr. Edward Yelin and Dr. Jennifer Barton of the University of California, ...
Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation
... Biotechnology), which
reduces the toxic form of amyloid by preventing the
interaction of amyloid
with copper and zinc in the brain.
-- A 84-week, Phase II ... to Prana, PBT2 reduces the toxic form of
beta amyloid by preventing the
interaction of beta amyloid with copper and
zinc. MPACs have been shown to restore ...
IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a Phase I/II Clinical Trial in Treatment-Naive HIV-Infected Patients
... four NNRTI-resistance mutations.
Safety, Pharmacokinetics and Drug-Drug
interaction Data in Healthy
Volunteers
A phase I study was conducted to evaluate the ... the absorption of IDX899. Additionally, in a
single-dose drug-drug
interaction study assessing the combination of either
100 or 800 mg IDX899 and 100 mg ...
Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium
... mandated that ibuprofen products now
carry a warning that there may be an
interaction between ibuprofen and
aspirin, which might render aspirin therapy less ... preventing and treating diseases. (1) Capone ML et al. Pharmacodynamic
interaction of naproxen with
low-dose aspirin in healthy subjects. J Am Coll Cardiol ...
Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
... for the clinical
development of brostallicin. Occurrence and mode of the
interaction between brostallicin and the
human glutathione transferases GSTP1-1 and ... were also presented on the mechanism of action of brostallicin and
its
interaction with glutathione transferases. "It is well established that
both ...
Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks
... wide-ranging potential for unmet medical needs,
including chronic respiratory infections of the lung. In the case of
Fluidosomes(TM)-tobramycin, the
interaction between tobramycin and the
microbial cell is triggered when the liposomes undergo a fusion process with
the outer membrane of the bacterial cell ....
Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline
...
"One of the issues raised by this study - and other recent Alzheimer's and mild cognitive impairment therapy trials - concerns a possible
interaction between certain therapies and genetic status. This issue needs to be explored more completely in future trials," Thies added.
Memory ...
Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints
... an endogenous neurotransmitter and metabolite of GABA. While the precise mechanism of action is unknown, the effects may be mediated in part through
interaction with GABA(B) and GHB receptors. Sodium oxybate is the active ingredient in XYREM(R), approved by the FDA and marketed by Jazz Pharmaceuticals in the ...
Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia
... an endogenous neurotransmitter and metabolite of GABA. While the precise mechanism of action is unknown, the effects may be mediated in part through
interaction with GABA(B) and GHB receptors. Sodium oxybate is the active ingredient in XYREM(R), approved by the FDA for the treatment of excessive daytime ...
Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research
... eight finalist teams met in-person with the SAC to present the plans for their research, and respond to questions about their projects - a level of
interaction between applicants and reviewers that is unique in a scientific review process. The SAC made recommendations for the further development of ...
Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
... response mediator protein-2 (CRMP-2), an important target that affects the way that nerves differentiate and grow. The precise nature of the
interaction between Vimpat(R) and CRMP-2 and between CRMP-2 and seizure control is not known.
About Epilepsy
Epilepsy is a chronic neurological disorder ...
PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS
... Medicine at the University Children's Hospital Zurich, Switzerland.
Previous DSCG therapies were only moderately effective, since the
interaction of the very hygroscopic properties of DSCG with the drug delivery system were not understood.
"We believe our novel, higher concentrated, low ...
Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
... risk of serious infections has been seen in clinical trials of other TNF blocking agents used in combination with anakinra or abatacept. Formal drug
interaction studies have not been performed with rituximab or natalizumab; however because of the nature of the adverse events seen with these combinations with ...
New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure
... Lupus Erythematosus
Thiazide diuretics have been reported to cause exacerbation or activation of systemic lupus erythematosus.
Lithium
interaction
Lithium generally should not be given with thiazides.
Adverse Events
The withdrawal rates due to adverse events (AEs) were ...
Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG
... platform offers wide-ranging potential for unmet medical needs,
including other respiratory diseases. In the case of Fluidosome-tobramycin,
the
interaction between tobramycin and the microbial cell is triggered when
the liposomes attach to the outer cell membrane. Tobramycin then leaches into
the inner ...
Doctors Urge Precaution to Shield Against Swine Flu
... helps to support NK cell activity in people with low NK cell function, improving the coordination of many aspects of immune response, including the
interaction of dendritic macrophage cells, T-cells and B-cells, resulting in improved health.
The benefit of AHCC's NK Cell supporting effect, and its role ...
Autism Genes Discovered; Help Shape Connections Among Brain Cells
... of the autism spectrum disorders (ASDs), a group of childhood neurodevelopmental disorders that cause impairments in verbal communication, social
interaction and behavior. Currently estimated to affect as many as one in 150 U.S. children, ASDs are known from family studies to be strongly influenced by ...
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
... our resources on advancing the most promising programs in our pipeline."
Key Developments
Lexicon completed a drug-drug
interaction study of LX2931 with methotrexate in patients with rheumatoid arthritis in March 2009. Top line results from the trial indicated that LX2931 ...
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
... for patients worldwide, today reported that its poster entitled, "Binding properties of the anti-EGFR monoclonal antibody, nimotuzumab, limit
interaction with the EGFR in renal and epidermal cells", has been accepted for presentation at the American Association for Cancer Research's (AACR) 100th Annual ...
Dermatologists Caution That Severe Cases of Psoriasis Can Be Associated With Other Serious Medical Conditions
... of patients with psoriasis have a family history of the disease. While the exact cause of psoriasis is unknown, it is believed to occur due to an
interaction of multiple genes, the immune system and the environment, according to Dr. Gelfand. The disease can be localized, affecting only the elbows or scalp, ...
New Overall Survival Study Results Confirm Oral Xeloda(R) plus Oxaliplatin (XELOX) is Comparable to FOLFOX-4 for the First-Line Treatment of Advanced Colorectal Cancer
... have higher levels of TP than does normal tissue, more 5-FU is delivered to the tumor than to other tissue.
A clinically important drug
interaction between Xeloda and warfarin has been demonstrated; altered coagulation parameters and/or bleeding and death have been reported. Clinically ...
Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
... in these studies and there are few exclusions of commonly
prescribed drugs or need for dose adjustments based on the known vicriviroc
drug-drug
interaction profile. The two studies involve a total of more than
850 patients and are currently ongoing at more than 160 sites in North
America, Latin America, ...
Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
... two studies on SPI-256, a novel investigational
HIV protease inhibitor (PI). One study based on an in vitro analysis
demonstrates that the mode of
interaction of SPI-256 with HIV protease
provides a rationale for its high potency and high genetic barrier to
resistance. The second study conducted in healthy ...
Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics
... allow us to quantify
subtle changes in ATP turnover, mitochondrial uncoupling or respiratory
chain inhibition that can immediately identify an
interaction of a compound
with the cell's energy generation pathways. Prior to the Seahorse, such
studies were restricted to laborious single oxygen consumption ...
Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
... advances have
established the key role of neurohormones in regulating appetite and energy
balance, as well as the importance of studying the
interaction among these
hormones (within the brain) to uncover their full therapeutic potential.
Amylin scientists discovered that combination treatment with ...
Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections
... platform opens broad applicability for unmet medical needs
including other respiratory diseases. In the case of the Fluidosome
tobramycin(R), the
interaction between tobramycin and the microbial cell is
triggered when the liposomes attach to the outer cell membrane. Tobramycin
then leaches into the inner ...
Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
... were
observed during the treatment period.
Two additional studies were also completed that evaluated the potential
for a pharmacokinetic drug-drug
interaction between IDX899 and other drugs
for the treatment of HIV-1, as well as the safety and tolerability of
IDX899 when administered in combination with ...
Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
... background treatment with Truvada(R) (emtricitabine and tenofovir
disoproxil fumarate), in the third quarter of this year. A recently
completed drug
interaction study with RDEA806 and Truvada confirmed the
lack of drug-drug interactions between these agents, paving the way for
initiation of the Phase 2b ....
VIRxSYS to Host a Web Conference to Announce Clinical Trial Update
... that binds to HIV, a cell adhesion molecule known as integrin
alpha 4 beta 7 that is found to direct CD4 T cell traffic to GALT and
enhance cellular
interaction through forming synapses between T cells. This
was interesting and welcome news for VIRxSYS because VRX-496 transduced CD4
T cells have a high ...
Stroke Study Reveals a Key Target For Improving Treatment
... within the brain, by accident. The culprit: tPA's tendency
to act upon a protein called PDGF-CC, and the PDGF-alpha receptor that it
binds to. This
interaction causes the usually impervious "blood-brain
barrier" to become porous, leading to leakage. Gleevec inhibits the
PDGF-alpha receptor, apparently ...
New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
... Systemic Lupus Erythematosus
Thiazide diuretics have been reported to cause exacerbation or
activation of systemic lupus erythematosus.
Lithium
interaction Lithium generally should not be given with thiazides.
Adverse Events -- The withdrawal rates due to adverse events (AEs) were similar with ...
New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder
... and when treating patients with dysphagia and swallowing
disorders.
Welchol reduces gastrointestinal absorption of some drugs. Drugs with a
known
interaction with colesevelam (glyburide,levothyroxine, and oral
contraceptives [ethinyl estradiol, norethindrone]) should be administered
at least 4 hours prior ...
Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated
... and when treating patients with dysphagia and swallowing
disorders.
Welchol reduces gastrointestinal absorption of some drugs. Drugs with a
known
interaction with colesevelam (glyburide, levothyroxine, and oral
contraceptives [ethinyl estradiol, norethindrone]) should be administered
at least 4 hours prior ...